Amicus Therapeutics Names Dr. Jay Barth Chief Medical Officer

Biopharmaceutical company Amicus Therapeutics has named board-certified pediatric gastroenterologist Jay Barth, MD, its Chief Medical Officer.

Advertisement

Dr. Barth has more than 15 years of experience in the medical field, clinical research and drug development. Prior to his role with Amicus, Dr. Barth worked with PTC Therapeutics.

He is a member of the American Gastroenterological Association, American College of Gastroenterology and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

More Articles on Gastroenterology:
The Biggest Challenges in GI Reimbursement: 3 Gastroenterologists Share Insight
AGA: Important Quality Improvement Dates for Gastroenterologists
Gastroenterology Retrospective: 3 Statistics on Physician Choices

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.